- Securities Registration: Employee Benefit Plan (S-8)
June 30 2009 - 6:01AM
Edgar (US Regulatory)
As
Filed With the Securities and Exchange Commission on June 30, 2009
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
ENDOLOGIX, INC.
(Exact name of Registrant as specified in its charter)
|
|
|
Delaware
|
|
68-0328265
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
11 Studebaker, Irvine, California 92618
(949) 595-7200
(Address, including zip code, and telephone number, including area code of registrants principal executive offices)
2006 EMPLOYEE STOCK PURCHASE PLAN
(Full title of the plan)
John McDermott
President and Chief Executive Officer
Endologix, Inc.
11 Studebaker, Irvine, California 92618
(949) 595-7200
(Name, address, including zip code, and telephone number, including area code of agent for service)
Copies to:
Lawrence B. Cohn
Michael A. Hedge
Stradling Yocca Carlson & Rauth,
660 Newport Center Drive, Suite 1600
Newport Beach, California 92660
(949) 725-4000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large
accelerated
filer
o
|
Accelerated
filer
þ
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed Maximum
|
|
|
Proposed Maximum
|
|
|
Amount of
|
|
|
Title of Securities to
|
|
|
Amount to be
|
|
|
Offering Price
|
|
|
Aggregate
|
|
|
Registration
|
|
|
be Registered
|
|
|
Registered (1)
|
|
|
Per Share (2)
|
|
|
Offering Price
|
|
|
Fee
|
|
|
Common Stock ($0.001 par value)
|
|
|
1,500,000 shares
|
|
|
$
|
3.18
|
|
|
|
$
|
4,770,000
|
|
|
|
$
|
266.16
|
|
|
|
|
|
|
|
(1)
|
|
Includes an indeterminate number of additional shares of the Registrants common stock which
may be necessary to adjust the number of shares issued pursuant to the 2006 Employee Stock
Purchase Plan as the result of any future stock splits, stock dividends or similar adjustments to the
Registrants outstanding common stock.
|
|
(2)
|
|
Estimated solely for the purpose of calculating the registration fee, in accordance with Rule
457(h)(1) under the Securities Act of 1933, as amended (the Securities Act), on the basis of
the price of securities of the same class, as determined in accordance with Rule 457(c) under
the Securities Act, using the average of the high and low prices reported by The Nasdaq Global
Market for our common stock on June 25, 2009, which was $3.18 per share.
|
EXPLANATORY NOTE
This Registration Statement has been prepared in accordance with General Instruction E to Form
S-8 and relates to an increase of 1,500,000 shares, or from 558,734 shares to 2,058,734 shares, of
common stock of Endologix, Inc. (the Registrant) reserved for issuance under the Registrants
2006 Employee Stock Purchase Plan (the Plan), which was approved by the Registrants board of
directors on December 11, 2008 and subsequently approved by the Registrants stockholders at the
Registrants Annual Meeting held on June 11, 2009. 558,734 shares of the Registrants common stock
have previously been registered for issuance under the Plan pursuant to Registration Statements on
Form S-8 (File Nos. 333-136370 and 333-152774).
2
TABLE OF CONTENTS
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The contents of the Registrants previously filed Registration Statements on Forms S-8 (File
Nos. 333-136370 and 333-152774) relating to shares issued under the Registrants 2006 Employee
Stock Purchase Plan are hereby incorporated by reference.
Item 8
.
Exhibits.
The following exhibits are filed as part of this registration statement:
|
|
|
Exhibit Number
|
|
Description
|
4.1
|
|
Amended and Restated
Certificate of
Incorporation
(Incorporated by reference
to Exhibit 4.1 to the
Registrants Registration
Statement on Form S-8,
filed with the Securities
and Exchange Commission on
August 7, 2006).
|
4.2
|
|
Amended and Restated
Bylaws (Incorporated by
reference to Exhibit 3.2
to the Registrants Annual
Report on Form 10-K filed
with the Securities and
Exchange Commission on
March 29, 2001).
|
4.3
|
|
Specimen Certificate of
Common Stock (Incorporated
by reference to Exhibit
4.1 to the Registrants
Amendment No. 2 to
Registration Statement on
Form S-1, No. 333-04560,
filed with the Securities
and Exchange Commission on
July 10, 1996).
|
5.1
|
|
Opinion of Stradling Yocca Carlson & Rauth, a
Professional Corporation.
|
10.1
|
|
2006 Employee Stock Purchase Plan, as amended
through June 11, 2009 (Incorporated by reference to
Exhibit 10.1 to the Registrants Current Report on
Form 8-K, filed with the Securities and Exchange
Commission on June 17, 2009).
|
23.1
|
|
Consent of Stradling Yocca Carlson & Rauth, a
Professional Corporation (included in Exhibit 5.1).
|
23.2
|
|
Consent of PricewaterhouseCoopers LLP.
|
24.1
|
|
Power of Attorney (included on signature page to
the Registration Statement).
|
3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Irvine, State of California, on the 29th day of June,
2009.
|
|
|
|
|
|
ENDOLOGIX, INC.
|
|
|
By:
|
/s/ John McDermott
|
|
|
|
John McDermott
|
|
|
|
President and Chief Executive Officer
|
|
|
POWER OF ATTORNEY
We, the undersigned directors and officers of Endologix, Inc., do hereby constitute and
appoint John McDermott and Robert J. Krist, or either of them, our true and lawful attorneys and
agents, to do any and all acts and things in our name and behalf in our capacities as directors and
officers and to execute any and all instruments for us and in our names in the capacities indicated
below, which said attorneys and agents, or either of them, may deem necessary or advisable to
enable said corporation to comply with the Securities Act of 1933, as amended, and any rules,
regulations, and requirements of the Securities and Exchange Commission, in connection with this
registration statement, including specifically, but without limitation, power and authority to sign
for us or any of us in our names and in the capacities indicated below, any and all amendments
(including post-effective amendments) to this registration statement, or any related registration
statement that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of
1933, as amended; and we do hereby ratify and confirm all that the said attorneys and agents, or
either of them, shall do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the date indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
President, Chief Executive Officer and Director
|
|
June 29, 2009
|
John McDermott
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
Chief Financial Officer and Secretary
|
|
June 29, 2009
|
Robert J. Krist
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
|
|
Chairman of the Board
|
|
June 29, 2009
|
Franklin D. Brown
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
June 29, 2009
|
Paul McCormick
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
June 29, 2009
|
Roderick de Greef
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
June 29, 2009
|
Jeffrey F. ODonnell
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
June 29, 2009
|
Gregory D. Waller
|
|
|
|
|
4
EXHIBIT INDEX
|
|
|
Exhibit Number
|
|
Description
|
4.1
|
|
Amended and Restated
Certificate of
Incorporation
(Incorporated by reference
to Exhibit 4.1 to the
Registrants Registration
Statement on Form S-8,
filed with the Securities
and Exchange Commission on
August 7, 2006).
|
4.2
|
|
Amended and Restated
Bylaws (Incorporated by
reference to Exhibit 3.2
to the Registrants Annual
Report on Form 10-K filed
with the Securities and
Exchange Commission on
March 29, 2001).
|
4.3
|
|
Specimen Certificate of
Common Stock (Incorporated
by reference to Exhibit
4.1 to the Registrants
Amendment No. 2 to
Registration Statement on
Form S-1, No. 333-04560,
filed with the Securities
and Exchange Commission on
July 10, 1996).
|
5.1
|
|
Opinion of Stradling Yocca Carlson & Rauth, a
Professional Corporation.
|
10.1
|
|
2006 Employee Stock Purchase Plan, as amended
through June 11, 2009 (Incorporated by reference to
Exhibit 10.1 to the Registrants Current Report on
Form 8-K, filed with the Securities and Exchange
Commission on June 17, 2009).
|
23.1
|
|
Consent of Stradling Yocca Carlson & Rauth, a
Professional Corporation (included in Exhibit 5.1).
|
23.2
|
|
Consent of PricewaterhouseCoopers LLP.
|
24.1
|
|
Power of Attorney (included on signature page to
the Registration Statement).
|
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Nov 2023 to Nov 2024